elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33869257-0D0F4765-ABA7-4C0B-94AC-38118D49F5B8
Q33869257-0D0F4765-ABA7-4C0B-94AC-38118D49F5B8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33869257-0D0F4765-ABA7-4C0B-94AC-38118D49F5B8
MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer.
P2860
Q33869257-0D0F4765-ABA7-4C0B-94AC-38118D49F5B8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33869257-0D0F4765-ABA7-4C0B-94AC-38118D49F5B8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c81f6270dcb357e099eeaeb655cfba7bec2183c0
P2860
Inactivation of the p53 pathway in retinoblastoma.